✨
AI Summary
- Andy Ramelmeir explains Sangamo's in-house manufacturing strategy.
- Building a cGMP AAV manufacturing facility for cell and gene therapies.
- Broad discussion on cell and gene therapy manufacturing considerations.
Guests on This Episode
AR
Andy Ramelmeier
1 podcast appearance